Operating Lease, Right-of-Use Asset of Longboard Pharmaceuticals, Inc. from 30 Sep 2021 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Longboard Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 30 Sep 2021 to 30 Sep 2024.
  • Longboard Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2024 was $3,731,000, a 646% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Longboard Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $3,731,000 +$3,231,000 +646% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $3,855,000 +$3,266,000 +554% 30 Jun 2024 10-Q 01 Aug 2024 2024 Q2
Q1 2024 $3,977,000 +$3,296,000 +484% 31 Mar 2024 10-Q 02 May 2024 2024 Q1
Q4 2023 $472,000 -$264,000 -36% 31 Dec 2023 10-Q 07 Nov 2024 2024 Q3
Q3 2023 $500,000 -$324,000 -39% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 $589,000 +$234,000 +66% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 $681,000 +$243,000 +55% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $736,000 +$215,000 +41% 31 Dec 2022 10-K 12 Mar 2024 2023 FY
Q3 2022 $824,000 +$224,000 +37% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $355,000 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $438,000 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 $521,000 31 Dec 2021 10-K 02 Mar 2023 2022 FY
Q3 2021 $600,000 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.